Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

ClinicalTrials.gov ID: NCT00117949

Public ClinicalTrials.gov record NCT00117949. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center, Ascending, Single Dose Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Population pharmacokinetic and pharmacodynamic data from Study FE200486 CS06 and FE200486 CS02 provided further knowledge of the optimal dose regimens for FE200486 (degarelix). Both studies were to guide dose selection for phase III. In addition, safety and tolerance data were generated.

Study identification

NCT ID
NCT00117949
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
82 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Jan 2004 (Actual)
Completion
Jan 2004 (Actual)
Last update posted
May 23, 2011

2002 – 2004

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
12
Facility City State ZIP Site status
Advanced Urology Medical Center Anaheim California 92801 —
South Orange County Medical Research Center Laguna Woods California 92653 —
San Bernardino Urological Associates Medical Group San Bernardino California 92404 —
Western Clinical Research Torrance California 90505 —
Urology Associate PC' Denver Colorado 80210 —
SW Florida Urological Associates Fort Myers Florida 33907 —
Pinellas Urology, Inc. St. Petersburg Florida 33710 —
Drs. Werner, Murdock & Francis, PA Greenbelt Maryland 20770 —
Nevada Urology Associates Reno Nevada 89511 —
Urology Specialists of Oklahoma, Inc. Tulsa Oklahoma 74104 —
Urology Clinics of NorthTexas, PA Dallas Texas 75231 —
Urology San Antonio Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00117949, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2011 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00117949 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →